Cannabis UseNCT04316741

Brief Intervention Combined With Health Coaching Via Social Media for Cannabis Use

A study testing Snapcoach in people with Cannabis Use, run by University of Michigan at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Trial summary

The purpose of the study is to develop and test social media interventions to help young people increase well-being and reduce risky behaviors. The study will help researchers learn about ways to deliver wellness information in a way that is appealing and helpful to young people who use Snapchat. Read more about this study

Who is it for?: Ages 18 to 25 years
Conditions the study is for: Cannabis Use
What is being tested?: Snapcoach
Type of treatment: Lifestyle or therapy programme
Could I receive a placebo?: No, everyone receives an active treatment
How many people: 63 participants
Where: 1 siteUnited States
Study dates: 19 Oct 2020to 21 Feb 2022
Phase: Interventional
Are there results?: Yes, posted in the registrySummary in the doctors' view

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

Ages 18 to 25 years
All sexes
No healthy volunteers
Adult

Who may be able to join

Individuals seen in the Emergency Department at Hurley Medical Center who meet these criteria
self-report of weekly or more frequent cannabis use for past 3 months
past month Snapchat use
ability to consent
English-speaking
between ages 18-25
smart phone ownership

Who cannot join

Emergency Department presentation for suicidality and/or acute psychosis, being in police custody, or present with psychological distress requiring intensive social work (e.g. sexual assault)
having a medical cannabis card

Trial locations and contacts

1 site in 1 country.

United States1 site

Hurley Medical Center
Flint, Michigan, 48503

Other trials in United States

About this study

Official title: Harnessing Social Media to Reduce Cannabis Use Among Adolescents and Emerging Adults in an Urban Emergency Department

Conditions: Cannabis Use
Being tested: Snapcoach

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

SnapcoachBehavioural
A brief motivational interviewing-based intervention combined with health coaching via social media for 4 weeks

Study groups in NCT04316741
Study group	Role	What they receive
Brief Intervention+Health Coaching	Experimental	Brief intervention with social-media delivered health coaching Receives: Behavioral: Snapcoach
Control	No intervention	Enhanced usual care brochure plus attention control with social media messaging

What is being measured

The primary outcome is the main question the study is designed to answer.

Brief Intervention Acceptability
Acceptability rating completed by participants for the brief intervention session
Measured: Immediate post-test administered after the session
Snapchat Acceptability Rating
Acceptability rating completed by participants for the Snapchat-delivered health coaching.
Item: In general, I enjoyed the Snapchat messages from the SnapCoach team. (Not at all, A little, Somewhat, Very, Extremely)
Measured: 1 month
Brief Intervention Feasibility
% of participants assigned to condition who complete the brief intervention
Measured: Immediate
Snapchat Health Coaching Feasibility
% of participants who complete key activities (e.g., % who add health coach on Snapchat)
Measured: Up to 1 month
Snapchat Health Coaching Feasibility
% of participants who complete key activities (e.g., % who reply to at least 1 Snapchat message)
Measured: Up to 1 month

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

19 Oct 202021 Feb 2022

First posted20 Mar 2020
Study start19 Oct 2020
Primary completion21 Feb 2022
Study completion21 Feb 2022

Resources

Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
Posted resultsParticipant flow, outcome measures and adverse events reported by the sponsor.
Other trials for Cannabis UseStudies of the same condition, open and under way.
More trials run by University of MichiganThe sponsor's other registered studies.
What the trial phases meanHow a treatment moves from first tests in people to approval.

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design

Study type: Interventional
Phase: Phase N/A
Primary purpose: Health services research
Allocation: Randomised
Intervention model: Parallel groups
Masking: Double blind
Who is masked: Investigator, Outcomes assessor
Enrolment: 63 participants (actual)

IDs, dates and publications

ClinicalTrials.gov ID: NCT04316741
Sponsor's protocol ID: HUM00139068
Other IDs: R34DA045712
Status last verified: Dec 2022
First submitted: 19 Mar 2020
Last updated: 30 Dec 2022
Results posted: Yes, on ClinicalTrials.gov
Data monitoring committee: No
FDA-regulated drug: No
FDA-regulated device: No
Individual data sharing: No

Want to know more?

The sponsor has not listed a contact. The official record may have more details.

Talk to your doctor first and take this page with you. Only the study team can confirm whether you can join.

Questions to ask the study team

What is the study trying to find out?
What would I need to do, and how often would I visit?
Could I receive a placebo instead of the treatment?
What are the possible risks and benefits for me?
Will it cost me anything? Are travel or time paid for?
Can I keep seeing my own doctor during the study?
What happens when the study ends?

See locations

Not yet recruiting
Substance Use and Media Preferences
Substance Use Behavior, Cannabis Intoxication
RecruitingObservational study
Study of an Oral Fluid Testing Approach
Cannabis Use, Cannabis Intoxication
Active, not recruitingPhase 1
Psilocybin-assisted Treatment for Cannabis Use Disorder
Cannabis Use Disorder
RecruitingObservational study
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
Breast Carcinoma, Colorectal Carcinoma
Not yet recruitingEarly Phase 1
Lung Health and Breath Biomarkers: Acute Effects of Inhaled Cannabis
Cannabis Use, Tobacco

All Cannabis Use trials

Study at a glance

From the registry record, last updated by the sponsor on 30 Dec 2022. Recruitment status is as the sponsor reported it: confirm with the study team.

Official title: Harnessing Social Media to Reduce Cannabis Use Among Adolescents and Emerging Adults in an Urban Emergency Department
ClinicalTrials.gov ID: NCT04316741
Acronym / sponsor ID: HUM00139068
Conditions: Cannabis Use
Study type: Interventional
Recruitment status: Completed
Enrolment: 63 participants (actual)
Lead sponsor: University of MichiganUniversity, hospital or other
Collaborators: National Institute on Drug Abuse (NIDA)
Study start: 19 Oct 2020 (actual)
Primary completion: 21 Feb 2022 (actual)
Study completion: 21 Feb 2022 (actual)
First posted: 20 Mar 2020 (actual)
Results: Posted 30 Dec 2022

Clinical summary

The research question as the sponsor registered it. This describes what the study plans to test, not what it found.

Study design

Primary purpose: Health services research
Allocation: Randomised
Intervention model: Parallel groups
Masking: Double blind (investigator, outcomes assessor)
Number of arms: 2

Arm	Type	Receives
Brief Intervention+Health Coaching	Experimental	Behavioral: SnapcoachBrief intervention with social-media delivered health coaching
Control	No intervention	–Enhanced usual care brochure plus attention control with social media messaging

Who may qualify

Ages: 18 to 25 years
Sex: All
Healthy volunteers: Not accepted
Age groups: Adult

Key inclusion criteria (7 listed)

Individuals seen in the Emergency Department at Hurley Medical Center who meet these criteria
self-report of weekly or more frequent cannabis use for past 3 months
past month Snapchat use
ability to consent
English-speaking

Key exclusion criteria (2 listed)

Emergency Department presentation for suicidality and/or acute psychosis, being in police custody, or present with psychological distress requiring intensive social work (e.g. sexual assault)
having a medical cannabis card

Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.

Interventions

Intervention	Type	Arms
SnapcoachA brief motivational interviewing-based intervention combined with health coaching via social media for 4 weeks	Behavioural	Brief Intervention+Health Coaching

Primary outcome

Brief Intervention Acceptability
Time frame: Immediate post-test administered after the session
Acceptability rating completed by participants for the brief intervention session
Snapchat Acceptability Rating
Time frame: 1 month
Acceptability rating completed by participants for the Snapchat-delivered health coaching. Item: In general, I enjoyed the Snapchat messages from the SnapCoach team. (Not at all, A little, Somewhat, Very, Extremely)
Brief Intervention Feasibility
Time frame: Immediate
% of participants assigned to condition who complete the brief intervention
Snapchat Health Coaching Feasibility
Time frame: Up to 1 month
% of participants who complete key activities (e.g., % who add health coach on Snapchat)
Snapchat Health Coaching Feasibility
Time frame: Up to 1 month
% of participants who complete key activities (e.g., % who reply to at least 1 Snapchat message)

Results and safety

Results posted to the registry on 30 Dec 2022, as reported by the sponsor. Figures are copied from the record, not re-analysed. Full results on ClinicalTrials.gov.

Participant flow

Group	Started	Completed
Brief Intervention+Health Coaching	30	29
Control	28	27

Primary outcome: Brief Intervention Acceptability

Time frame: Immediate post-test administered after the session. Count of participants. Unit: Participants

Measure	Brief Intervention+Health Coaching n = 24
Liked it/Liked it a lot	23
Neutral	1
Disliked it/disliked it a lot	0

Population analysed: These data were not collected from the participants in the "Control" Arm/Group. These data refer to the intervention only. 24 participants who completed ratings of the intervention session immediately post-intervention. Acceptability measured by the following item: How much did you enjoy talking to your health coach today?

Primary outcome: Snapchat Acceptability Rating

Time frame: 1 month. Count of participants. Unit: Participants

Measure	Brief Intervention+Health Coaching n = 22
Not at all	0
A little/somewhat	4
Very much/extremely	18

Population analysed: These data were not collected from the participants in the "Control" Arm/Group. These data refer to the intervention only. 22 participants in intervention condition who completed a post-test at 1-month after enrollment (i.e., conclusion of intervention period)

Primary outcome: Brief Intervention Feasibility

Time frame: Immediate. Count of participants. Unit: Participants

Measure	Brief Intervention+Health Coaching n = 30
completed brief intervention session	26
did not complete brief intervention session	4

Population analysed: Individuals randomized to intervention condition These data were not collected from the participants in the "Control" Arm/Group. These data refer to the intervention only.

Primary outcome: Snapchat Health Coaching Feasibility

Time frame: Up to 1 month. Count of participants. Unit: Participants

Measure	Brief Intervention+Health Coaching n = 30
% who added coaches on Snapchat	29
% who did not add coaches on Snapchat	1

Population analysed: 30 individuals randomized to the intervention group These data were not collected from the participants in the "Control" Arm/Group. These data refer to the intervention only.

Adverse events

Time frame: From baseline enrollment to 3-month follow-up.. Other adverse events reported at 0% frequency or more

Group	Serious adverse events	Other adverse events	Deaths
Brief Intervention+Health Coaching	0 of 30 (0%)	0 of 30 (0%)	0 of 30
Control	0 of 28 (0%)	0 of 28 (0%)	0 of 28

Limitations and caveats (from the sponsor): This work occurred in the COVID-19 pandemic ina front-line clinical setting (Emergency Department in an socio-economically under-resourced community). COVID-related shutdowns of in-person research, COVID protocols (e.g., inability to approach participants in droplet precautions), and staffing retention (e.g., abiltiy to employ individuals who would work in a COVID frontline setting) impeded recruitment of the originally planned sample size, with impacts also on retention.

Loading the posted results from ClinicalTrials.gov…

Research links

Official record on ClinicalTrials.govLast updated by the sponsor 30 Dec 2022.
Posted resultsParticipant flow, baseline, all outcome measures and adverse events.
Individual participant dataSharing planned: No

Related trials for Cannabis Use

Not yet recruiting
Substance Use and Media Preferences
Substance Use Behavior, Cannabis Intoxication
RecruitingObservational study
Study of an Oral Fluid Testing Approach
Cannabis Use, Cannabis Intoxication
Active, not recruitingPhase 1
Psilocybin-assisted Treatment for Cannabis Use Disorder
Cannabis Use Disorder
RecruitingObservational study
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
Breast Carcinoma, Colorectal Carcinoma
Not yet recruitingEarly Phase 1
Lung Health and Breath Biomarkers: Acute Effects of Inhaled Cannabis
Cannabis Use, Tobacco

Referral and contact

AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.

Erin Bonar principal investigator

University of Michigan

1 site in 1 country: see every site and its status.

Questions about this trial

What is this clinical trial studying?

A study testing Snapcoach in people with Cannabis Use, run by University of Michigan at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 7 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 30 Dec 2022. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Yes. Results are posted in the registry (first posted 30 Dec 2022). A summary is in the For doctors view, and the full results are on ClinicalTrials.gov.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Brief Intervention Acceptability (time frame: Immediate post-test administered after the session). The study lists 5 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT04316741.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 30 Dec 2022.